These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38182080)

  • 1. Pyroptosis: Mechanisms and links with diabetic cardiomyopathy.
    Liu P; Zhang Z; Chen H; Chen Q
    Ageing Res Rev; 2024 Feb; 94():102182. PubMed ID: 38182080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications.
    Liu Z; Chen Y; Mei Y; Yan M; Liang H
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pyroptosis in diabetic cardiomyopathy: an updated review.
    Wang G; Ma TY; Huang K; Zhong JH; Lu SJ; Li JJ
    Front Endocrinol (Lausanne); 2023; 14():1322907. PubMed ID: 38250736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
    Zhang L; Ai C; Bai M; Niu J; Zhang Z
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications.
    Ding K; Song C; Hu H; Yin K; Huang H; Tang H
    Oxid Med Cell Longev; 2022; 2022():3790721. PubMed ID: 36111168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
    PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
    Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
    Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway.
    Yang L; Cheng CF; Li ZF; Huang XJ; Cai SQ; Ye SY; Zhao LJ; Xiong Y; Chen DF; Liu HL; Ren ZX; Fang HC
    Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37114562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-223-3p promotes pyroptosis of cardiomyocyte and release of inflammasome factors via downregulating the expression level of SPI1 (PU.1).
    Zhao S; Tan Y; Qin J; Xu H; Liu L; Wan H; Zhang C; Fan W; Qu S
    Toxicology; 2022 Jun; 476():153252. PubMed ID: 35792203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
    Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
    Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis-Related Inflammasome Pathway: A New Therapeutic Target for Diabetic Cardiomyopathy.
    Cai Z; Yuan S; Luan X; Feng J; Deng L; Zuo Y; Li J
    Front Pharmacol; 2022; 13():842313. PubMed ID: 35355717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin improves diabetic cardiomyopathy-induced cardiac remodeling by regulating GSDMD-mediated pyroptosis through MITOL/STING signaling.
    Lu L; Shao Y; Xiong X; Ma J; Zhai M; Lu G; Jiang L; Jin P; Tang J; Yang J; Liu Y; Duan W; Liu J
    Biomed Pharmacother; 2024 Feb; 171():116007. PubMed ID: 38171238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
    Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
    Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review.
    Jia Y; Li D; Yu J; Jiang W; Liao X; Zhao Q
    Front Cardiovasc Med; 2022; 9():985020. PubMed ID: 36061533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
    Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
    Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications.
    Liu P; Zhang Z; Cai Y; Yang Y; Yuan J; Chen Q
    Eur J Med Chem; 2023 May; 253():115336. PubMed ID: 37031528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM).
    Xuan X; Zhang S
    Phytother Res; 2023 Dec; 37(12):5495-5508. PubMed ID: 37622685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroptosis in diabetes and diabetic nephropathy.
    Cao Z; Huang D; Tang C; Lu Y; Huang S; Peng C; Hu X
    Clin Chim Acta; 2022 Jun; 531():188-196. PubMed ID: 35427562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.
    Cai L; Tan Y; Holland B; Wintergerst K
    Cardiovasc Toxicol; 2024 Feb; 24(2):71-84. PubMed ID: 38321349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.